Type 2 Diabetes Clinical Trial
Official title:
Physical Health in Midlife: Influences of Adversity and Relationships Over Time
The purpose of this study is to determine the effects of individual characteristics, life stresses, and relationships over time on psychosocial outcomes (e.g. marriage, parenting, work) and physical health
Research Procedures: If a patient choose to take part in this research study, they will
undergo these research procedures:
The patient will participate in a total of two meetings and four phone calls over the course
of the study (two and a half years). The meetings will be held at the beginning and end of
the two and a half year period. The first part of each meeting will take place at Beth
Israel Deaconess Medical Center (BIDMC) where they will sign this consent form and then be
interviewed for medical history, given a physical examination, and have blood tests
described below. The patient will then be transported to Judge Baker Children's Center
(JBCC), where they will have lunch, complete questionnaires, and participate in taped
interviews (approximately 4 hours). The phone calls will be approximately every six months
and the patient will be contacted by the people at JBCC. More detailed information on the
study procedures is outlined below and on the JBCC consent form for the study.
Interviews, Questionnaires, and Phone calls: These aspects of the study are covered in the
Judge Baker Children's Center consent form. Briefly, the patient will be asked to discuss
relationships with their partner, family, and friends, their career, their current goals in
life, their health status, etc. These sessions will be recorded so that the patient's
answers can be coded and analyzed at a later time. All information will be kept strictly
confidential.
Medical Examination: The patient will arrive fasting to the medical examination. During the
medical exam, a physician will ask the patient questions about their physical health and
family history. The doctor will then conduct a physical examination which includes:
1. Glucose finger stick for diabetes screening
2. Vital signs (such as blood pressure) and anthropometrics (such as waist circumference).
3. Measuring the amount of fat in the patient's body using bioelectrical impedance
analysis. This test will measure the resistance to the naturally occurring flow of
electrical currents within the nerves and muscles using a few electrical sensors
(similar to the EKG) attached to the patient's wrist and ankle for less than a minute.
This procedure is not painful and uses the same principle as weighing oneself on a
scale that provides body mass index.
4. Measuring the patient body's ability to use sugar through an oral glucose tolerance
test (OGTT). A nurse will place an intravenous (IV) catheter (a small tube) in the
patient's arm. It will be taped to stay in place for approximately four hours. The
patient will drink a mixed nutrient drink called Boost. The patient's blood will be
drawn through the catheter 15 min after the Boost is given and then at 30-minute
intervals for 3 hours to measure how they metabolize the nutrient drink.
5. EKG
;
Observational Model: Cohort, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |